Imodium Multi-Symptom Relief and Kisqali Femara Co-Pack 600 mg-2.5 mg Dose
Determining the interaction of Imodium Multi-Symptom Relief and Kisqali Femara Co-Pack 600 mg-2.5 mg Dose and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: loperamide / simethicone
Brand name: Imodium Multi-Symptom Relief
Synonyms: n.a.
Generic Name: letrozole / ribociclib
Brand name: Kisqali Femara Co-Pack 200 mg-25 mg Dose, Kisqali Femara Co-Pack 400 mg-25 mg Dose, Kisqali Femara Co-Pack 600 mg-25 mg Dose
Synonyms: Kisqali Femara Co-Pack 200 mg-2.5 mg Dose, Kisqali Femara Co-Pack
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Imodium Multi-Symptom Relief-Kitabis Pak
- Imodium Multi-Symptom Relief-Kitabis Pak inhalation
- Imodium Multi-Symptom Relief-Klofensaid II
- Imodium Multi-Symptom Relief-Klonopin
- Imodium Multi-Symptom Relief-Klonopin Wafer
- Imodium Multi-Symptom Relief-Klonopin Wafers
- Kisqali Femara Co-Pack 600 mg-2.5 mg Dose-Imogam Rabies-HT
- Kisqali Femara Co-Pack 600 mg-2.5 mg Dose-Imogam Rabies-HT human
- Kisqali Femara Co-Pack 600 mg-2.5 mg Dose-Imogen
- Kisqali Femara Co-Pack 600 mg-2.5 mg Dose-Imotil
- Kisqali Femara Co-Pack 600 mg-2.5 mg Dose-Imovax Rabies
- Kisqali Femara Co-Pack 600 mg-2.5 mg Dose-Imovax Rabies human diploid cell